跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
triptolide prodrug
首页
药物
triptolide prodrug
triptolide prodrug
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Triptolide derivatives for modulation of apoptosis and immunosuppression
EP 2468277 A1
申请人: PHARMAGENESIS INC
优先权: 2003
EP
US
6 件公开
DRUG COMBINATION FOR THE TREATMENT OF STOMACH CANCER
EP 4447956 C0
申请人: MINNEAMRITA THERAPEUTICS LLC
优先权: 2023
EP
US
2 件公开
Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors
US 9993458 B2
申请人: INSTITUTE FOR CANCER RES
优先权: 2016
US
2 件公开
Treatment of acute myeloid leukemia
EP 1946758 A1
申请人: PF MEDICAMENT
优先权: 2007
EP
Water-soluble triptolide prodrug with polyethylene glycol as carrier as well as preparation method and application thereof
CN 104629036 A
申请人: UNIV FUJIAN MEDICAL
优先权: 2015
CN
Novel preparation method of multi-armed polyethylene glycol nano drug entrapping triptolide and hydroxycamptothecine
CN 107137720 A
申请人: UNIV BEIJING FORESTRY
优先权: 2017
CN
Choline carbonate prodrug as well as preparation method and application thereof
CN 115466269 A
申请人: UNIV FUDAN
优先权: 2021
CN
Active oxygen responsive triptolide prodrug immunoregulation hydrogel preparation as well as preparation method and application thereof
CN 120168394 A
申请人: UNIV SHANGHAI JIAOTONG
优先权: 2025
CN
Targeted ROS (reactive oxygen species) activated triptolide derivative as well as preparation method and application thereof
CN 120441641 A
申请人: WUHAN CHENXI BIOMEDICAL TECH CO LTD
优先权: 2025
CN
药物
反馈